in Pediatric Hematology-Oncology Certification Exam

in Pediatric Hematology-Oncology The pediatric hematology-oncology board exam recently restructured its immunotherapy content to reflect current clinical protocols, including CAR-T cell therapies and checkpoint inhibitors now standard in pediatric leukemia treatment. Candidates should prioritize updated guidelines on minimal residual disease monitoring and risk stratification frameworks that have shifted significantly in the past two years.